Article Citation
Yang HH, Huang Y, Zhou XC, Wang RN. Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis. World J Clin Cases 2022; 10(18): 6091-6104 [PMID: 35949827 DOI: 10.12998/wjcc.v10.i18.6091]
Please LOGIN to submit a new comment.